Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Coral García

No Difference in Effectiveness of Treatment Simplification to Boosted or Unboosted Atazanavir Plus Lamivudine in Virologically Suppressed in HIV-1-infected Patients

PLoS ONE

Multidisciplinary

2018

English

Related publications

Lipid Profile Improvement in Virologically Suppressed HIV-1-infected Patients Switched to Dolutegravir/Abacavir/Lamivudine: Data From the SCOLTA Project

Infection and Drug Resistance

Infectious Diseases

Pharmacology

2019

English

Abacavir/Lamivudine Versus Tenofovir/Emtricitabine in Virologically Suppressed Patients Switching From Ritonavir-Boosted Protease Inhibitors to Raltegravir

AIDS Research and Human Retroviruses

English

Switching to Unboosted Atazanavir Improves Glucose Tolerance in Highly Pretreated HIV-1 Infected Subjects

European Journal of Endocrinology

English

Switch From Enfuvirtide to Raltegravir in Virologically Suppressed HIV-1 Infected Patients: Effects on Level of Residual Viremia and Quality of Life

Journal of Clinical Virology

Virology

Infectious Diseases

2009

English

Nevirapine-Raltegravir Combination, a NRTI and PI/r Sparing Regimen, as Maintenance Antiretroviral Therapy in Virologically Suppressed HIV-1-infected Patients

English

Cost-Effectiveness Analysis of Tenofovir/Emtricitabine and Abacavir/Lamivudine in Combination With Efavirenz or Atazanavir/Ritonavir for Treatment-Naive Adults With Hiv-1 Infection in the United Kingdom

English

External Validation of the Bilirubin–Atazanavir Nomogram for Assessment of Atazanavir Plasma Exposure in HIV-1-Infected Patients

AAPS Journal

Pharmaceutical Science

2012

English

Plasma Concentrations of Boosted and Unboosted Atazanavir Are Predicted by 63396C>T SNP in the PXR Gene

Journal of the International AIDS Society

English

HIV Lamivudine Resistance Mutations in HBV Co-Infected Romanian Patients

Journal of the International AIDS Society

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Coral García

No Difference in Effectiveness of Treatment Simplification to Boosted or Unboosted Atazanavir Plus Lamivudine in Virologically Suppressed in HIV-1-infected Patients

Related publications

Lipid Profile Improvement in Virologically Suppressed HIV-1-infected Patients Switched to Dolutegravir/Abacavir/Lamivudine: Data From the SCOLTA Project

Abacavir/Lamivudine Versus Tenofovir/Emtricitabine in Virologically Suppressed Patients Switching From Ritonavir-Boosted Protease Inhibitors to Raltegravir

Switching to Unboosted Atazanavir Improves Glucose Tolerance in Highly Pretreated HIV-1 Infected Subjects

Switch From Enfuvirtide to Raltegravir in Virologically Suppressed HIV-1 Infected Patients: Effects on Level of Residual Viremia and Quality of Life

Nevirapine-Raltegravir Combination, a NRTI and PI/r Sparing Regimen, as Maintenance Antiretroviral Therapy in Virologically Suppressed HIV-1-infected Patients

Cost-Effectiveness Analysis of Tenofovir/Emtricitabine and Abacavir/Lamivudine in Combination With Efavirenz or Atazanavir/Ritonavir for Treatment-Naive Adults With Hiv-1 Infection in the United Kingdom

External Validation of the Bilirubin–Atazanavir Nomogram for Assessment of Atazanavir Plasma Exposure in HIV-1-Infected Patients

Plasma Concentrations of Boosted and Unboosted Atazanavir Are Predicted by 63396C>T SNP in the PXR Gene

HIV Lamivudine Resistance Mutations in HBV Co-Infected Romanian Patients